Found: 25
Select item for more details and to access through your institution.
A phase II trial to evaluate the combination of pixantrone and obinutuzumab for patients with relapsed aggressive lymphoma: Final results of the prospective, multicentre GOAL trial.
- Published in:
- British Journal of Haematology, 2022, v. 198, n. 3, p. 482, doi. 10.1111/bjh.18161
- By:
- Publication type:
- Article
Reinduction therapy with everolimus in combination with dexamethasone, high‐dose cytarabin and cisplatinum in patients with relapsed or refractory classical Hodgkin lymphoma: an experimental phase I/II multicentre trial of the German Hodgkin Study Group (GHSG HD‐R3i)
- Published in:
- British Journal of Haematology, 2022, v. 196, n. 3, p. 606, doi. 10.1111/bjh.17878
- By:
- Publication type:
- Article
Doubling rituximab in high‐risk patients with aggressive B‐cell lymphoma ‐results of the DENSE‐R‐MegaCHOEP trial.
- Published in:
- British Journal of Haematology, 2019, v. 184, n. 5, p. 760, doi. 10.1111/bjh.15710
- By:
- Publication type:
- Article
Correction to: Phase I dose escalation study of BI 836826 (CD37 antibody) in patients with relapsed or refractory B cell non-Hodgkin lymphoma.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Correction to: Phase I dose escalation study of BI 836826 (CD37 antibody) in patients with relapsed or refractory B-cell non-Hodgkin lymphoma.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Phase I dose escalation study of BI 836826 (CD37 antibody) in patients with relapsed or refractory B-cell non-Hodgkin lymphoma.
- Published in:
- Investigational New Drugs, 2020, v. 38, n. 5, p. 1472, doi. 10.1007/s10637-020-00916-3
- By:
- Publication type:
- Article
90-yttrium-ibritumomab tiuxetan as first-line treatment for follicular lymphoma: updated efficacy and safety results at an extended median follow-up of 9.6 years.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Concepts in immuno-oncology: tackling B cell malignancies with CD19-directed bispecific T cell engager therapies.
- Published in:
- Annals of Hematology, 2020, v. 99, n. 10, p. 2215, doi. 10.1007/s00277-020-04221-0
- By:
- Publication type:
- Article
Unusual transformation of primary extranodal marginal zone B cell lymphoma of the uterus into a nodal follicular lymphoma grade IIIB.
- Published in:
- 2019
- By:
- Publication type:
- Letter to the Editor
Safety of AFM11 in the treatment of patients with B-cell malignancies: findings from two phase 1 studies.
- Published in:
- Trials, 2023, v. 24, n. 1, p. 1, doi. 10.1186/s13063-022-06982-7
- By:
- Publication type:
- Article
Safety of AFM11 in the treatment of patients with B-cell malignancies: findings from two phase 1 studies.
- Published in:
- Trials, 2023, v. 24, n. 1, p. 1, doi. 10.1186/s13063-022-06982-7
- By:
- Publication type:
- Article
A phase II study of the PI3K inhibitor copanlisib in combination with the anti-CD20 monoclonal antibody rituximab for patients with marginal zone lymphoma: treatment rationale and protocol design of the COUP-1 trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Oncological outcome and recurrence pattern analysis after involved-field irradiation in combination with rituximab for early-stage nodal and extranodal follicular lymphoma.
- Published in:
- Strahlentherapie und Onkologie, 2020, v. 196, n. 8, p. 705, doi. 10.1007/s00066-020-01624-w
- By:
- Publication type:
- Article
U-DCS: characterization of the first permanent human dendritic sarcoma cell line.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-77471-7
- By:
- Publication type:
- Article
Microarray-based genomic profiling reveals novel genomic aberrations in follicular lymphoma which associate with patient survival and gene expression status.
- Published in:
- Genes, Chromosomes & Cancer, 2009, v. 48, n. 1, p. 39, doi. 10.1002/gcc.20617
- By:
- Publication type:
- Article
Gain of chromosome arm 9p is characteristic of primary mediastinal b-cell lymphoma (MBL): Comprehensive molecular cytogenetic analysis and presentation of a novel MBL cell line.
- Published in:
- Genes, Chromosomes & Cancer, 2001, v. 30, n. 4, p. 393, doi. 10.1002/1098-2264(2001)9999:9999<::AID-GCC1105>3.0.CO;2-I
- By:
- Publication type:
- Article
Targeting CD19 in diffuse large B‐cell lymphoma: An expert opinion paper.
- Published in:
- Hematological Oncology, 2022, v. 40, n. 4, p. 505, doi. 10.1002/hon.3013
- By:
- Publication type:
- Article
Micronuclei in peripheral blood from patients after cytostatic therapy mainly arise ex vivo from persistent damage.
- Published in:
- Mutagenesis, 2009, v. 24, n. 4, p. 351, doi. 10.1093/mutage/gep015
- By:
- Publication type:
- Article
Chimeric antigen receptor (CAR) T-cell therapy as a treatment option for patients with B-cell lymphomas: perspectives on the therapeutic potential of Axicabtagene ciloleucel.
- Published in:
- Cancer Management & Research, 2019, v. 11, p. 2393, doi. 10.2147/CMAR.S163225
- By:
- Publication type:
- Article
Therapy of nodal Follicular Lymphoma (WHO grade 1/2) in clinical stage I/II using response adapted Involved Site Radiotherapy in combination with Obinutuzumab (Gazyvaro) - GAZAI Trial (GAZyvaro and response adapted Involved-site Radiotherapy): a study protocol for a single-arm, non-randomized, open, national, multi-center phase II trial.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Chemoimmunotherapy with ofatumumab in combination with CHOP in previously untreated follicular lymphoma.
- Published in:
- British Journal of Haematology, 2012, v. 157, n. 4, p. 438, doi. 10.1111/j.1365-2141.2012.09086.x
- By:
- Publication type:
- Article
Value of comparative genomic hybridization and fluorescence in situ hybridization for molecular diagnostics in multiple myeloma.
- Published in:
- British Journal of Haematology, 2003, v. 122, n. 2, p. 193, doi. 10.1046/j.1365-2141.2003.04417.x
- By:
- Publication type:
- Article
Perspektiven der CAR-T-Zell-Therapie.
- Published in:
- Der Pathologe, 2020, v. 41, p. 149, doi. 10.1007/s00292-020-00819-3
- By:
- Publication type:
- Article
Targetable alterations in primary extranodal diffuse large B‐cell lymphoma.
- Published in:
- EJHaem, 2022, v. 3, n. 3, p. 688, doi. 10.1002/jha2.428
- By:
- Publication type:
- Article
CD5.
- Published in:
- European Journal of Immunology, 2010, v. 40, n. 7, p. 2060, doi. 10.1002/eji.200940113
- By:
- Publication type:
- Article